The Future of Oral Cholera Vaccine

At the moment we are working on an oral cholera vaccine candidate for commercial markets. We plan to go into a phase three clinical trial at the end of 2024. As soon as that's in clinical trial we will then shift our focus to producing clinical batches for the mRNA COVID vaccine. After that we're looking for other candidates but we intend to commercialize specifically the oral Cholera vaccine. The future of the COVID mRNA candidate most likely will not pursue that commercially, but we will certainly be ready with the mRNA technology to onboard a TB candidate or a malaria candidate as soon as those become available.